Hexo Corp. Completes C$34.5 Million At-the-Market Offering Program

Rhea-AI Summary

HEXO Corp has successfully completed its at-the-market equity program, selling a total of 33,921,979 common shares from June 18 to July 31, 2020. The sales generated gross proceeds of approximately C$34.5 million (C$17,248,047 and US$12,751,168). The funds raised are intended for general corporate purposes, including working capital and debt repayments. The ATM program operated under an equity distribution agreement with ATB Capital Markets and Oppenheimer & Co. No regulatory authority has approved the contents of this release.

Positive

• Raised approximately C$34.5 million through the ATM program.

Negative

• None.

OTTAWA, Aug. 13, 2020 (GLOBE NEWSWIRE) -- HEXO Corp. (“HEXO”, or the “Company”) (TSX: HEXO; NYSE: HEXO) today announced that it has completed its previously announced at-the-market equity program (the “ATM Program”).  Under the ATM Program, the Company sold an aggregate of 33,921,979 common shares between June 18, 2020 and July 31, 2020 through the Toronto Stock Exchange, the New York Stock Exchange and other marketplaces on which the common shares are listed, quoted or otherwise traded.  The common shares were sold at prevailing market prices for gross proceeds of C$17,248,047 and US$12,751,168, or total gross proceeds of C$34,497,272 after applying applicable US$-C$ exchange rates.

Distributions of the common shares through the ATM Program were made pursuant to the terms of an equity distribution agreement dated June 16, 2020 among the Company, ATB Capital Markets Inc., as Canadian agent, and Oppenheimer & Co. Inc., as U.S. agent.

The Company expects to use the net proceeds from the ATM Program for general corporate purposes, which may include: (i) working capital; (ii) capital expenditures; and (iii) debt repayments.

The offering under the ATM Program was made pursuant to a prospectus supplement dated June 16, 2020 (the "Prospectus Supplement") to the Company’s Canadian amended and restated short form base shelf prospectus dated December 14, 2018  (the "Base Shelf Prospectus"), and pursuant to a prospectus supplement dated June 16, 2020 (the "U.S. Prospectus Supplement") to the Company’s U.S. base prospectus (the "U.S. Base Prospectus") included in its registration statement on Form F-10 (the "Registration Statement") (File No. 333-228924) filed with the United States Securities and Exchange Commission on December 20, 2018. The Prospectus Supplement and the Base Shelf Prospectus are available on the SEDAR website maintained by the Canadian Securities Administrators at www.sedar.com, and the U.S. Prospectus Supplement, the U.S. Base Prospectus and the Registration Statement are available on EDGAR at the SEC’s website at www.sec.gov.

No securities regulatory authority has either approved or disapproved of the contents of this press release. This press release is for information purposes only and does not constitute an offer to sell or the solicitation of an offer to buy the common shares, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About HEXO

HEXO Corp is an award-winning consumer packaged goods cannabis company that creates and distributes innovative products to serve the global cannabis market. The Company serves the Canadian adult-use markets under its HEXO Cannabis, Up Cannabis and Original Stash brands, and the medical market under HEXO medical cannabis. For more information please visit hexocorp.com.

Forward Looking Statements

This press release contains forward-looking information and forward-looking statements within the meaning of applicable securities laws (“forward-looking statements”), including statements regarding the Company’s expected use of the net proceeds from the ATM Program. Forward-looking statements are based on certain expectations and assumptions and are subject to known and unknown risks and uncertainties and other factors that could cause actual events, results, performance and achievements to differ materially from those anticipated in these forward-looking statements, including that the Company’s use of proceeds of the ATM Program may differ from those indicated. Forward-looking statements should not be read as guarantees of future performance or results.

For additional information with respect to certain of these expectations, assumptions, risks, uncertainties and other factors, and risk factors relating to the Company and the Common Shares, reference should be made to the Prospectus Supplement and the Base Shelf Prospectus or the U.S. Prospectus Supplement and the U.S. Base Prospectus, as applicable, the Company’s annual information form dated October 28, 2019 and other continuous disclosure filings, which are available on SEDAR at www.sedar.com and EDGAR at www.sec.gov. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements as a result of new information or future events, or for any other reason.

Investor Relations:
invest@HEXO.com
www.hexocorp.com

Media Relations:
(819) 317-0526
media@hexo.com

FAQ

What was the gross proceeds raised by HEXO through its ATM program?

HEXO raised approximately C$34.5 million through its ATM program.

What are the intended uses of the net proceeds from HEXO's ATM program?

The net proceeds from HEXO's ATM program are expected to be used for working capital, capital expenditures, and debt repayments.

During what period did HEXO sell shares under its ATM program?

HEXO sold shares under its ATM program from June 18, 2020, to July 31, 2020.

What agencies were involved in HEXO's ATM program?

ATB Capital Markets and Oppenheimer & Co. were the agencies involved in HEXO's ATM program.